NCT02570035 - Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease | Biotech Hunter

Enrollment

316

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Overactive BladderCardiovascular Disease

Interventions

DRUG

Mirabegron

oral

Trial Locations (28)

Site JP81013, Aichi

Site JP81014, Aichi

Site JP81005, Chiba

Site JP81006, Chiba

Site JP81007, Chiba

Site JP81026, Fukuoka

Site JP81027, Fukuoka

Site JP81001, Hokkaido

Site JP81002, Hokkaido

Site JP81021, Hyōgo

Site JP81022, Hyōgo

Site JP81023, Hyōgo

Site JP81024, Hyōgo

Site JP81025, Hyōgo

Site JP81028, Kagoshima

Site JP81011, Kanagawa

Site JP81012, Kanagawa

Site JP81003, Niigata

Site JP81016, Osaka

Site JP81017, Osaka

Site JP81018, Osaka

Site JP81019, Osaka

Site JP81020, Osaka

Site JP81004, Saitama

Site JP81015, Shizuoka

Site JP81008, Tokyo

Site JP81009, Tokyo

Site JP81010, Tokyo